Position in LLY
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$197,905
+$50,742 QoQ
Shares Held
165
+3.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#4,436
of 4,605 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PIN OAK INVESTMENT ADVISORS INC holds $4,178,060 across 13 Drug Manufacturers - General names. LLY ranks #5 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,063 | $1,793,790 | |
| 2 | ABBV |
AbbVie Inc.
|
2,819 | $709,373 | |
| 3 | PFE |
Pfizer Inc
|
24,253 | $584,012 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,079 | $395,651 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
165 | $197,905 | |
| 6 | NVS |
Novartis AG
|
1,253 | $196,370 | |
| 7 | BIIB |
Biogen Inc.
|
821 | $177,385 | |
| 8 | AMGN |
Amgen Inc
|
279 | $101,031 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $197,905 | 165 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $147,163 | 160 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $171,948 | 160 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $135,051 | 177 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $130,961 | 168 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $144,534 | 175 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $106 | 120 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $106,312 | 120 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $88,727 | 98 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $115,916 | 149 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $104,342 | 179 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $54,787 | 102 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $88,637 | 189 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $64,906 | 189 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $9,146 | 25 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,083 | 25 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,105 | 25 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $25,486 | 89 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $24,583 | 89 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $14,787 | 64 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $14,689 | 64 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $11,956 | 64 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $10,805 | 64 | Shares | Sole | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||